Characteristics of Health Care Personnel with COVID-19 - United States, February 12-April 9, 2020

CDC COVID-19 Response Team, Sherry L Burrer, Marie A de Perio, Michelle M Hughes, David T Kuhar, Sara E Luckhaupt, Clinton J McDaniel, Rachael M Porter, Benjamin Silk, Matthew J Stuckey, Maroya Walters, CDC COVID-19 Response Team, Sherry L Burrer, Marie A de Perio, Michelle M Hughes, David T Kuhar, Sara E Luckhaupt, Clinton J McDaniel, Rachael M Porter, Benjamin Silk, Matthew J Stuckey, Maroya Walters

Abstract

As of April 9, 2020, the coronavirus disease 2019 (COVID-19) pandemic had resulted in 1,521,252 cases and 92,798 deaths worldwide, including 459,165 cases and 16,570 deaths in the United States (1,2). Health care personnel (HCP) are essential workers defined as paid and unpaid persons serving in health care settings who have the potential for direct or indirect exposure to patients or infectious materials (3). During February 12-April 9, among 315,531 COVID-19 cases reported to CDC using a standardized form, 49,370 (16%) included data on whether the patient was a health care worker in the United States; including 9,282 (19%) who were identified as HCP. Among HCP patients with data available, the median age was 42 years (interquartile range [IQR] = 32-54 years), 6,603 (73%) were female, and 1,779 (38%) reported at least one underlying health condition. Among HCP patients with data on health care, household, and community exposures, 780 (55%) reported contact with a COVID-19 patient only in health care settings. Although 4,336 (92%) HCP patients reported having at least one symptom among fever, cough, or shortness of breath, the remaining 8% did not report any of these symptoms. Most HCP with COVID-19 (6,760, 90%) were not hospitalized; however, severe outcomes, including 27 deaths, occurred across all age groups; deaths most frequently occurred in HCP aged ≥65 years. These preliminary findings highlight that whether HCP acquire infection at work or in the community, it is necessary to protect the health and safety of this essential national workforce.

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Figures

FIGURE
FIGURE
Daily number of COVID-19 cases, by date of symptom onset, among health care personnel and non-health care personnel (N = 43,986), — United States, February 12–April 9, 2020 Abbreviation: COVID-19 = coronavirus disease 2019. * Onset date was calculated for 5,892 (13%) cases where onset date was missing. This was done by subtracting 4 days (median interval from symptom onset to specimen collection date) from the date of earliest specimen collection. Cases with unknown onset and specimen collection dates were excluded. † Ten-day window is used to reflect the upper quartile in lag between the date of symptom onset and date reported to CDC.

References

    1. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report – 81. Geneva, Switzerland: World Health Organization; 2020.
    1. CDC. Coronavirus disease 2019 (COVID-19): cases in U.S. Atlanta, GA: US Department of Health and Human Services, CDC; 2020.
    1. US Department of Homeland Security. Advisory memorandum on identification of essential critical infrastructure workers during COVID-19 response. Washington, DC: US Department of Homeland Security; 2020.
    1. Guan WJ, Ni ZY, Hu Y, et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;NEJMoa2002032.
    1. Livingston E, Bucher K. Coronavirus disease 2019. (COVID-19) in Italy. JAMA. Epub March 17, 2020.
    1. Kimball A, Hatfield KM, Arons M, et al.; Public Health – Seattle & King County; CDC COVID-19 Investigation Team. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility—King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep 2020;69:377–81. 10.15585/mmwr.mm6913e1
    1. Wei WE, Li Z, Chiew CJ, Yong SE, Toh MP, Lee VJ. Presymptomatic transmission of SARS-CoV-2—Singapore, January 23–March 16, 2020. MMWR Morb Mortal Wkly Rep 2020;69:411–5. 10.15585/mmwr.mm6914e1
    1. Bialek S, Boundy E, Bowen V, et al.; CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12–March 16, 2020. MMWR Morb Mortal Wkly Rep 2020;69:343–6. 10.15585/mmwr.mm6912e2
    1. Chow N, Fleming-Dutra K, Gierke R, et al.; CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019—United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep 2020;69:382–6. 10.15585/mmwr.mm6913e2
    1. Heinzerling A, Stuckey MJ, Scheuer T, et al. Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient—Solano County, California, February 2020. MMWR Morb Mortal Wkly Rep 2020;69. Epub April 14, 2020. 10.15585/mmwr.mm6915e5

Source: PubMed

3
Předplatit